Order Article Reprints

Miciaccia M, Rizzo F, Centonze A, Cavallaro G, Contino M, Armenise D, Baldelli OM, Solidoro R, Ferorelli S, Scarcia P, et al. Harmaline to Human Mitochondrial Caseinolytic Serine Protease Activation for Pediatric Diffuse Intrinsic Pontine Glioma Treatment. Pharmaceuticals. 2024; 17(1):135. https://doi.org/10.3390/ph17010135

Miciaccia, Morena, Francesca Rizzo, Antonella Centonze, Gianfranco Cavallaro, Marialessandra Contino, Domenico Armenise, Olga Maria Baldelli, Roberta Solidoro, Savina Ferorelli, Pasquale Scarcia, and et al. 2024. "Harmaline to Human Mitochondrial Caseinolytic Serine Protease Activation for Pediatric Diffuse Intrinsic Pontine Glioma Treatment" Pharmaceuticals 17, no. 1: 135. https://doi.org/10.3390/ph17010135

Miciaccia, M., Rizzo, F., Centonze, A., Cavallaro, G., Contino, M., Armenise, D., Baldelli, O. M., Solidoro, R., Ferorelli, S., Scarcia, P., Agrimi, G., Zingales, V., Cimetta, E., Ronsisvalle, S., Sipala, F. M., Polosa, P. L., Fortuna, C. G., Perrone, M. G., & Scilimati, A. (2024). Harmaline to Human Mitochondrial Caseinolytic Serine Protease Activation for Pediatric Diffuse Intrinsic Pontine Glioma Treatment. Pharmaceuticals, 17(1), 135. https://doi.org/10.3390/ph17010135